The lack of effects of zinc and nitric oxide in initial state of pilocarpine-induced seizures

Seizure

Volumn 16, Issue 5, 2007, Pages 410-416

  Noyan, Behzat ^a   Jensen, Morten Skovgaard ^b   Danscher, Gorm ^b  

^a ULUDAG UNIVERSITY   (Turkey)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Immersion AMG; Nitric oxide; Seizure; TSQ fluorescence; Zinc

Indexed keywords

EDETATE CALCIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PILOCARPINE; SODIUM CHLORIDE; TOLUENESULFONAMIDE DERIVATIVE; ZINC;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOMETALLOGRAPHY; BRAIN SURGERY; CLINICAL OBSERVATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; FLUORESCENCE ANALYSIS; HIPPOCAMPUS; HISTOCHEMISTRY; LATENT PERIOD; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SEIZURE;

ANIMALS; BEHAVIOR, ANIMAL; CHELATING AGENTS; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EDETIC ACID; ENZYME INHIBITORS; FUNCTIONAL LATERALITY; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; ZINC;

EID: 34249703370     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2007.02.012     Document Type: Article

References (47)

1. Hawkins R.D., Son H., and Arancio O. Nitric oxide as a retrograde messenger during long-term potentiation in hippocampus. Prog Brain Res 118 (1998) 155-172
2. Sattler R., Xiong Z., Lu W.Y., Hafner M., MacDonald J.F., and Tymianski M. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science 284 (1999) 1845-1848
3. Fedele E., and Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog Neurobiol 58 (1999) 89-120
4. Ferraro G., and Sardo P. Nitric oxide and brain hyperexcitability. In Vivo 18 (2004) 357-366
5. Ledo A., Frade J., Barbosa R.M., and Laranjinha J. Nitric oxide in brain: diffusion, targets and concentration dynamics in hippocampal subregions. Mol Aspects Med 25 (2004) 75-89
6. Wojtal K., Gniatkowska-Nowakowska A., and Czuczwar S.J. Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs?. Pol J Pharmacol 55 (2003) 535-542
7. Del-Bel E.A., Oliveira P.R., Oliveira J.A., Mishra P.K., Jobe P.C., and Garcia-Cairasco N. Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz J Med Biol Res 30 (1997) 971-979
8. Starr M.S., and Starr B.S. Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor l-NAME. Pharmacol Biochem Behav 45 (1993) 321-325
9. Dzoljic E., De Vries R., and Dzoljic M.R. Anticonvulsant activity of new and potent inhibitors of nitric oxide synthase. Brain Res Bull 43 (1997) 191-195
10. Van Leeuwen R., De Vries R., and Dzoljic M.R. 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur J Pharmacol 28 (1995) 7211-7213
11. Przegalinski E., Baran L., and Siwanowicz J. The role of nitric oxide in chemically-and electrically-induced seizures in mice. Neurosci Lett 217 (1996) 145-148
12. Brown G.C., and Borutaite V. Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 33 (2002) 1440-1450
13. Patel M.N. Oxidative stress, mitochondrial dysfunction, and epilepsy. Free Radic Res 36 (2002) 1139-1146
14. Frederickson C.J., Cuajungco M.P., LaBuda C.J., and Suh S.W. Nitric oxide causes apparent release of zinc from presynaptic boutons. Neuroscience 11 (2002) 5471-5474
15. Cuajungco M.P., and Lees G.J. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya. Brain Res 799 (1998) 118-129
16. 2+ inhibit nitric-oxide synthase through an interaction with the reductase domain. J Biol Chem 275 (2000) 14070-14076
17. 2+ ion. Biochemistry 34 (1995) 15091-15095
18. Cuajungco M.P., and Lees G.J. Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 4 (1997) 137-169
19. Frederickson C.J., Suh S.W., Silva D., Frederickson, Cathy J., and Thompson R.B. Importance of zinc in the central nervous system: the zinc-containing neuron. J Nutr 130 (2000) 1471S-1483S
20. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 34 (2000) 137-148
21. Kay A.R. Evidence for chelatable zinc in the extracellular space of the hippocampus, but little evidence for synaptic release of Zn. J Neurosci 23 (2003) 6847-6855
22. Frederickson C.J., and Bush A.I. Synaptically released zinc: physiological functions and pathological effects. Biometals 14 (2001) 353-366
23. Molnar P., and Nadler J.V. Synaptically-released zinc inhibits N-methyl-d-aspartate receptor activation at recurrent mossy fiber synapses. Brain Res 910 (2001) 205-207
24. Weiss J.H., and Sensi S.L. Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci 23 (2000) 365-371
25. Frederickson C.J., Hernandez M.D., and McGinty J.F. Translocation of zinc may contribute to seizure-induced death of neurons. Brain Res 480 (1989) 317-321
26. Weiss J.H., Sensi S.L., and Koh J.Y. Zn(2+): a novel ionic mediator of neural injury in brain disease. Trends Pharmacol Sci 21 (2000) 395-401
27. Cole T.B., Robbins C.A., Wenzel H.J., Schwartzkroin P.A., and Palmiter R.D. Seizures and neuronal damage in mice lacking vesicular zinc. Epilepsy Res 39 (2000) 153-169
28. Frederickson C.J., Maret W., and Cuajungco M.P. Zinc and excitotoxic brain injury: a new model. Neuroscientist 10 (2004) 18-25
29. Lee J.Y., Cole T.B., Palmiter R.D., and Koh J.Y. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci 20 (2000) RC79
30. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32 (1972) 281-294
31. Danscher G., Stoltenberg M., Bruhn M., Sondergaard C., and Jensen D. Immersion autometallography: histochemical in situ capturing of zinc ions in catalytic zinc-sulfur nanocrystals. J Histochem Cytochem 52 (2004) 1619-1625
32. Frederickson C.J., Kasarskis E.J., Ringo D., and Frederickson R.E. A quinoline flourescense method for visualizing and assaying the histochemically reactive zinc (bouton zinc) in the brain. J Neurosci Methods 20 (1987) 91-103
33. Noyan B., and Gulec G. Effects of l-arginine on prevention and treatment of lithiumpilocarpine- induced status epilepticus. Physiol Res 49 (2000) 379-385
34. Bagetta G., Massoud R., Rodino P., Federici G., and Nistico G. Systemic administration of lithium chloride and tacrine increases nitric oxide synthase activity in the hippocampus of rats. Eur J Pharmacol 23 (1993) 761-764
35. Milatovic D., Gupta R.C., and Dettbarn W.D. Involvement of nitric oxide in kainic acid-induced excitotoxicity in rat brain. Brain Res 957 (2002) 330-337
36. Balcioglu A., and Maher T.J. Determination of kainic acid-induced release of nitric oxide using a novel hemoglobin trapping technique with microdialysis. J Neurochem 61 (1993) 2311-2313
37. Mitchell C.L., and Barnes M.I. Proconvulsant action of diethyldithiocarbamate in stimulation of the perforant path. Neurotoxicol Teratol 15 (1993) 165-171
38. Carrasco J., Penkowa M., Hadberg H., Molinero A., and Hidalgo J. Enhanced seizures and hippocampal neurodegeneration following kainic acid-induced seizures in metallothionein-I + II-deficient mice. Eur J Neurosci 12 (2000) 2311-2322
39. Bancila V., Nikonenko I., Dunant Y., and Bloc A. Zinc inhibits glutamate release via activation of pre-synaptic K channels and reduces ischaemic damage in rat hippocampus. J Neurochem 90 (2004) 1243-1250
40. Bymaster F.P., et al. Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 17 (2003) 1403-1410
41. Maslanski J.A., Powelt R., Deirmengiant C., and Patelt J. Assessment of the muscarinic receptor subtypes involved in pilocarpine-induced seizures in mice. Neurosci Lett 168 (1994) 225-228
42. Ormandy G.C., Jope R.S., and Snead III O.C. Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol 106 (1989) 172-180
43. Hughes P., Young D., and Dragunow M. MK-801 sensitizes rats to pilocarpine induced limbic seizures and status epilepticus. Neuroreport 4 (1993) 314-316
44. Lee J.M., Zipfel G.J., Park K.H., He Y.Y., Hsu C.Y., and Choi D.W. Zinc translocation accelerates infarction after mild transient focal ischemia. Neuroscience 115 (2002) 871-878
45. Suh S.W., Chen J.W., Motamedi M., Bell B., Listiak K., Pons N.F., et al. Evidence that synaptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 852 (2000) 268-273
46. Suh S.W., Thompson R.B., and Frederickson C.J. Loss of vesicular zinc and appearance of perikaryal zinc after seizures induced by pilocarpine. Neuroreport 12 (2001) 1523-1525
47. Frederickson C.J., Hernandez M.D., Goik S.A., Morton J.D., and McGinty J.F. Loss of zinc staining from hippocampal mossy fibers during kainic acid induced seizures: a histofluorescence study. Brain Res 446 (1988) 383-386